Asthma and smoking: A review
- PMID: 35901579
- DOI: 10.1016/j.resmer.2022.100916
Asthma and smoking: A review
Abstract
Asthma occurrence is often associated with cigarette smoking. Surprisingly, active smokers are excluded from most clinical studies. Prevalence of asthma associated with smoking appears to be similar to asthma in the general population. However, in active smokers, asthma tends to be more difficult to manage and more severe. Several studies have demonstrated a poor response to inhaled corticosteroids (ICS) and an accelerated decline of lung function. Smoking decreases exhaled NO rate and down-regulates ICS receptors, which is associated with increased oxidative stress. Data on biologic therapies are scarce. Finally, nicotine dependence seems higher in asthmatic patients and smoking cessation is thus more difficult.
Keywords: Asthma; Smoking; Treatment.
Copyright © 2022 SPLF and Elsevier Masson SAS. All rights reserved.
Conflict of interest statement
Conflict of interest Audrey Kamga: none. Dr Rochefort-Morel reported fees for board memberships or symposia from, GSK, ALK, Stallergenes, Chiesi, Menarini, Sanofi, Astra, Boerhinger, Mylan, Mundipharma. Dr Le Guen: none. Dr Ouksel reported receiving fees for board memberships or symposia from Novartis, Chiesi, GSK, Astra Zeneca, LFB and CSL Behring. Dr Pipet reported receiving fees for board memberships or symposia from Asten Santé, Astra-Zeneca Boehringer and Novartis. Dr Leroyer reported receiving fees for board memberships or symposia from GlaxoSmithKline, AstraZeneca, ALK, Chiesi, Ménarini, Novartis, Pfizer, Sanofi, and MSD.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical